Detailed Explanation
Dose escalation represents a fundamental methodology in early clinical development, providing a structured approach to exploring the safety and tolerability of increasing doses of an investigational product in humans. Beginning with doses predicted to be safe based on preclinical studies, investigators carefully advance to higher doses only after demonstrating adequate safety at each level. This methodical progression allows identification of the maximum tolerated dose while minimizing participant exposure to potentially harmful dose levels.